Gary D. Hammer

18.2k total citations · 2 hit papers
147 papers, 9.2k citations indexed

About

Gary D. Hammer is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Gary D. Hammer has authored 147 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Endocrinology, Diabetes and Metabolism, 62 papers in Molecular Biology and 57 papers in Surgery. Recurrent topics in Gary D. Hammer's work include Adrenal and Paraganglionic Tumors (56 papers), Cancer, Hypoxia, and Metabolism (41 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (35 papers). Gary D. Hammer is often cited by papers focused on Adrenal and Paraganglionic Tumors (56 papers), Cancer, Hypoxia, and Metabolism (41 papers) and Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (35 papers). Gary D. Hammer collaborates with scholars based in United States, Germany and Australia. Gary D. Hammer's co-authors include Tobias Else, Thomas J. Giordano, Barbra S. Miller, Holly A. Ingraham, Gerard M. Doherty, Paul G. Gauger, Alex C. Kim, Antônio Marcondes Lerário, Catherine E. Keegan and Aaron Sabolch and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Gary D. Hammer

139 papers receiving 9.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

2016 1.0k citations Stefan R. Bornstein, Bruno Allolio et al. The Journal of Clinical Endocrinology & Metabolism profile →
Adrenocortical Carcinoma

2013 575 citations Tobias Else, Victoria M. Raymond et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gary D. Hammer United States	53	4.2k	3.9k	3.3k	2.9k	2.0k	147	9.2k
Anna Spada Italy	46	3.5k 0.8×	1.2k 0.3×	2.6k 0.8×	491 0.2×	1.4k 0.7×	172	7.0k
Elisabetta Ferretti Italy	56	1.9k 0.5×	1.1k 0.3×	5.5k 1.7×	1.8k 0.6×	1.2k 0.6×	203	8.8k
Matthew M. Rechler United States	63	7.1k 1.7×	2.1k 0.5×	6.4k 1.9×	1.6k 0.6×	1.9k 1.0×	163	11.2k
Shern L. Chew United Kingdom	39	1.9k 0.5×	1.3k 0.3×	2.6k 0.8×	630 0.2×	779 0.4×	84	5.9k
Gilbert J. Cote United States	46	2.9k 0.7×	1.4k 0.4×	3.3k 1.0×	1.2k 0.4×	912 0.5×	141	7.3k
Richard N. Clayton United Kingdom	52	5.1k 1.2×	1.1k 0.3×	2.0k 0.6×	515 0.2×	1.2k 0.6×	181	9.2k
J. Zapf Switzerland	41	5.0k 1.2×	1.1k 0.3×	3.3k 1.0×	1.0k 0.4×	1.3k 0.6×	103	7.5k
Attila Patócs Hungary	33	1.4k 0.3×	1.2k 0.3×	2.0k 0.6×	1.7k 0.6×	426 0.2×	236	4.7k
S. Peter Nissley United States	50	4.1k 1.0×	1.4k 0.4×	3.9k 1.2×	693 0.2×	1.2k 0.6×	92	6.9k
Lee S. Weinstein United States	55	1.1k 0.3×	1.4k 0.4×	5.4k 1.6×	557 0.2×	3.7k 1.8×	184	10.4k

Countries citing papers authored by Gary D. Hammer

Since Specialization

Citations

This map shows the geographic impact of Gary D. Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary D. Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary D. Hammer more than expected).

Fields of papers citing papers by Gary D. Hammer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary D. Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary D. Hammer. The network helps show where Gary D. Hammer may publish in the future.

Co-authorship network of co-authors of Gary D. Hammer

This figure shows the co-authorship network connecting the top 25 collaborators of Gary D. Hammer. A scholar is included among the top collaborators of Gary D. Hammer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary D. Hammer. Gary D. Hammer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wolf, Katherine I., et al.. (2026). Prevalence and clinical characteristics of Lynch syndrome-associated adrenocortical carcinoma. Endocrine Related Cancer. 33(1).

Chan, Yuen San, Miao Zhang, Antônio Marcondes Lerário, et al.. (2025). β-catenin functions as a molecular adapter for disordered cBAF interactions. Molecular Cell. 85(16). 3041–3056.e9.

Dumontet, Typhanie, et al.. (2025). Adrenocortical stem cells in health and disease. Nature Reviews Endocrinology. 21(8). 464–481. 1 indexed citations

Lerário, Antônio Marcondes, Matthew Ullenbruch, Matthew Taylor, et al.. (2024). Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronism. Molecular and Cellular Endocrinology. 585. 112176–112176. 1 indexed citations

Liu, Lihua, Chris Stubben, Brian K. Lohman, et al.. (2023). Senescence-induced immune remodeling facilitates metastatic adrenal cancer in a sex-dimorphic manner. Nature Aging. 3(7). 846–865. 20 indexed citations

Mohan, Dipika R., Antônio Marcondes Lerário, Tobias Else, et al.. (2019). Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma. Clinical Cancer Research. 25(11). 3276–3288. 46 indexed citations

LaPensee, Christopher R., Jacqueline E. Mann, William E. Rainey, et al.. (2016). ATR-101, a Selective and Potent Inhibitor of Acyl-CoA Acyltransferase 1, Induces Apoptosis in H295R Adrenocortical Cells and in the Adrenal Cortex of Dogs. Endocrinology. 157(5). 1775–1788. 71 indexed citations

Bornstein, Stefan R., Bruno Allolio, Wiebke Arlt, et al.. (2016). Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 101(2). 364–389. 1010 indexed citations breakdown →

Hung, Holly A., et al.. (2015). Mouse models of adrenocortical tumors. Molecular and Cellular Endocrinology. 421. 82–97. 14 indexed citations

10.

Wood, Michelle A., et al.. (2013). Fetal adrenal capsular cells serve as progenitor cells for steroidogenic and stromal adrenocortical cell lineages in M. musculus. Development. 140(22). 4522–4532. 61 indexed citations

11.

Raymond, Victoria M., Jessica N. Everett, Larissa V. Furtado, et al.. (2013). Adrenocortical Carcinoma Is a Lynch Syndrome–Associated Cancer. Journal of Clinical Oncology. 31(24). 3012–3018. 134 indexed citations

12.

Simon, Derek P., Thomas J. Giordano, & Gary D. Hammer. (2012). Upregulated JAG1 Enhances Cell Proliferation in Adrenocortical Carcinoma. Clinical Cancer Research. 18(9). 2452–2464. 30 indexed citations

13.

Nasonkin, Igor O., R. DeC. Ward, Felix Beuschlein, et al.. (2011). Aged PROP1 Deficient Dwarf Mice Maintain ACTH Production. PLoS ONE. 6(12). e28355–e28355. 11 indexed citations

14.

Miller, Barbra S., Paul G. Gauger, Gary D. Hammer, Thomas J. Giordano, & Gerard M. Doherty. (2010). Proposal for modification of the ENSAT staging system for adrenocortical carcinoma using tumor grade. Langenbeck s Archives of Surgery. 395(7). 955–961. 55 indexed citations

15.

Giordano, Thomas J., Rork Kuick, Tobias Else, et al.. (2009). Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling. Clinical Cancer Research. 15(2). 668–676. 292 indexed citations

16.

Xu, Bin, Wei‐Hsiung Yang, Isabelle Gerin, et al.. (2009). Dax-1 and Steroid Receptor RNA Activator (SRA) Function as Transcriptional Coactivators for Steroidogenic Factor 1 in Steroidogenesis. Molecular and Cellular Biology. 29(7). 1719–1734. 98 indexed citations

17.

Olmos, David, R. Molife, Scott H. Okuno, et al.. (2007). Safety, tolerability and preliminary efficacy of the anti-IGF-IR monoclonal antibody CP-751,871 in patients with sarcomas and adrenocortical tumors.. Molecular Cancer Therapeutics. 6. 7 indexed citations

18.

Keegan, Catherine E., Janna Hutz, Katrin Koehler, et al.. (2007). Novel polymorphisms and lack of mutations in the ACD gene in patients with ACTH resistance syndromes. Clinical Endocrinology. 67(2). 168–174. 2 indexed citations

19.

Else, Tobias & Gary D. Hammer. (2005). Genetic analysis of adrenal absence: agenesis and aplasia. Trends in Endocrinology and Metabolism. 16(10). 458–468. 58 indexed citations

20.

Beuschlein, Felix, Christopher A. Mutch, Yvonne M. Ulrich‐Lai, et al.. (2002). Steroidogenic Factor-1 Is Essential for Compensatory Adrenal Growth Following Unilateral Adrenalectomy. Endocrinology. 143(8). 3122–3135. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact